Biondvax Pharmaceuticals's total assets is $20M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2023), BVXV shows a total assets of $20M. That compares with $86M in the prior-year period — down 76.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BVXV's total assets is now $20M (was $86M) — a 76.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biondvax Pharmaceuticals is outperforming or lagging.
Tracking BVXV's total assets over time shows whether Biondvax Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $86M in the prior-year period — down 76.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Biondvax Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $20M) with ownership activity and broader fundamentals.
Biondvax Pharmaceuticals's total assets is $20M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.